menu
    • menu

    Company profile for MyBiotics Pharma Ltd

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The importance of the gut microbiome has long been recognized, but only recently has the importance of gut bacteria imbalance been recognized as a crucial factor in various diseases and health conditions. The company’s proprietary technologies, MyCrobe and SuperDonor, allow us to be in the front of the microbiome field. Both technologies resolve the three critical factors in the probiotic development market. Delivery, Target...
    The importance of the gut microbiome has long been recognized, but only recently has the importance of gut bacteria imbalance been recognized as a crucial factor in various diseases and health conditions. The company’s proprietary technologies, MyCrobe and SuperDonor, allow us to be in the front of the microbiome field. Both technologies resolve the three critical factors in the probiotic development market. Delivery, Targeting and Colonization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MyBiotics Pharma LtdIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    2 Ilan Ramon, 2nd floor, P.O box 4061, Science Park, Ness Ziona 7414001
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://mybiotix.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/mybiotix-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MyBiotics completes Phase I trial for MBX-SD-202 whole microbiome treatment
    MyBiotics completes Phase I trial for MBX-SD-202 whole microbiome treatment

    24 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mybiotics-announces-successful-completion-of-the-phase-i-trial-for-its-mbx-sd-202-whole-microbiome-treatment-driving-an-innovative-path-to-new-restoration-therapies-using-microbiome-culturing-technology-301466369.html

    PRNEWSWIRE
    24 Jan 2022
    Share Share
    Pharmed and MyBio Partner to Bring First European Produced
    Pharmed and MyBio Partner to Bring First European Produced

    07 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210707005930/en

    BUSINESSWIRE
    07 Jul 2021
    Share Share
    Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome
    Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome

    06 Apr 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/hadassah-and-mybiotics-to-collaborate-for-the-discovery-of-microbiome-based-therapy-for-improving-cancer-immunotherapy-301261954.html

    PRNEWSWIRE
    06 Apr 2021
    Share Share
    Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome
    Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome

    05 Apr 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/hadassah-and-mybiotics-to-collaborate-for-the-discovery-of-microbiome-based-therapy-for-improving-cancer-immunotherapy-301261954.html

    PRNEWSWIRE
    05 Apr 2020
    Share Share
    USFDA issues response letter for new drug application for insulin glargine: Biocon
    USFDA issues response letter for new drug application for insulin glargine: Biocon

    02 Sep 2019

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/usfda-issues-response-letter-for-new-drug-application-for-insulin-glargine-biocon/articleshow/70923376.cms

    ECONOMIC TIMES
    02 Sep 2019
    Share Share
    MyBiotics Signs Second Option to License Agreement with Ferring Holding for Microbiome-Based Therapies
    MyBiotics Signs Second Option to License Agreement with Ferring Holding for Microbiome-Based Therapies

    05 Mar 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mybiotics-signs-second-option-to-license-agreement-with-ferring-holding-for-microbiome-based-therapies-300607926.html

    PR NEWSWIRE
    05 Mar 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search